follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Matinas BioPharma moves to Bedminster

By

Back to Top Comments Print

Biopharmaceutical company Matinas BioPharma Holdings Inc. announced today it has established its corporate headquarters in Bedminster.

According to the announcement, the company, which recently closed a $15 million financing, is now positioned to begin advancing the development of omega-3 lead product candidate, MAT9001, for the treatment of severe hypertriglyceridemia and mixed dyslipidemia.

"We believe [establishing headquarters in New Jersey] strategically positions us very well to have access to great talent and the financial and pharmaceutical communities," Chief Executive Roelof Rongen said in a statement.

Write to the Editorial Department at editorial@njbiz.com

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top